Related Experiment Videos
Ovarian neoplasms in children
M A Skinner1, M G Schlatter, S A Heifetz
1Department of Surgery, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Indianapolis.
Archives of Surgery (Chicago, Ill. : 1960)
|August 1, 1993
Summary
Pediatric ovarian neoplasms are rare, often germ-cell tumors. While most are benign, aggressive malignant tumors, particularly sex cord/stromal types, can be unpredictable despite early-stage diagnosis and treatment.
Area of Science:
- Pediatric Oncology
- Gynecologic Oncology
- Tumor Biology
Background:
- Ovarian neoplasms are uncommon in children.
- Germ-cell tumors are the predominant type in pediatric patients, differing from adult populations.
- Clinical presentation varies, including abdominal pain, mass, or hormonal disturbances.
Purpose of the Study:
- To review the clinical presentation, treatment, and outcomes of ovarian neoplasms in pediatric patients.
- To analyze the types, stages, and survival rates of these tumors.
- To identify prognostic factors and treatment responses.
Main Methods:
- Retrospective review of medical records for 29 girls with ovarian neoplasms treated between 1976 and 1992.
- Analysis of patient demographics, tumor characteristics, treatment modalities, and outcomes.
- Follow-up duration ranged from 6 months to 7.5 years, averaging 3.0 years for malignant cases.
Main Results:
- Seventeen tumors were benign and 12 were malignant; germ-cell tumors predominated (n=17).
- Most malignant neoplasms (7/10) were diagnosed at stage I.
- Overall survival was high (100% for benign, 70% for malignant), but aggressive behavior was noted in some malignant types, including sex cord/stromal tumors.
Conclusions:
- Ovarian tumors in children are rare and typically germ-cell in origin.
- While many are benign, some malignant pediatric ovarian tumors exhibit aggressive behavior and poor response to adjuvant therapy.
- Malignant sex cord/stromal cell tumors warrant particular attention due to their unpredictable nature, even at early stages.